Please enter the email address you used to register, then we will send you a link to choose a new password
Bolt Biotherapeutics (NASDAQ:BOLT) reported quarterly losses of $(4.46) per share which beat the analyst consensus estimate of ...
-SEC Filing
Lake Street analyst Chad Messer initiates coverage on Bolt Biotherapeutics (NASDAQ:BOLT) with a Buy rating and announces Pri...
Stifel analyst Stephen Willey maintains Bolt Biotherapeutics (NASDAQ:BOLT) with a Hold and lowers the price target from $1.2...
Bolt Biotherapeutics (NASDAQ:BOLT) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of ...
Conference call and webcast on Monday, May 12, 2025, at 2:30 p.m. PT / 5:30 p.m. ET- Bolt Biotherapeutics (NASDAQ:BOLT), a biop...
CEA-targeted ISAC elicits complete responses in mice and is well-tolerated in NHPsPD-L1 ISAC directly activates and reprograms ...
HC Wainwright & Co. analyst Edward White reiterates Bolt Biotherapeutics (NASDAQ:BOLT) from Neutral to Neutral.
Stifel analyst Stephen Willey maintains Bolt Biotherapeutics (NASDAQ:BOLT) with a Hold and lowers the price target from $1.5...